Short Interest in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Increases By 207.1%

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 4,300 shares, an increase of 207.1% from the December 15th total of 1,400 shares. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is presently 0.4 days.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

An institutional investor recently bought a new position in Invesco Nasdaq Biotechnology ETF stock. ORG Partners LLC acquired a new position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,067 shares of the company’s stock, valued at approximately $25,000. ORG Partners LLC owned about 0.07% of Invesco Nasdaq Biotechnology ETF as of its most recent SEC filing.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of NASDAQ IBBQ opened at $21.58 on Thursday. The company has a 50 day simple moving average of $22.41 and a two-hundred day simple moving average of $23.31. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $20.14 and a fifty-two week high of $24.84. The company has a market capitalization of $38.20 million, a price-to-earnings ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were given a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.